NO20091809L - Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel - Google Patents

Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel

Info

Publication number
NO20091809L
NO20091809L NO20091809A NO20091809A NO20091809L NO 20091809 L NO20091809 L NO 20091809L NO 20091809 A NO20091809 A NO 20091809A NO 20091809 A NO20091809 A NO 20091809A NO 20091809 L NO20091809 L NO 20091809L
Authority
NO
Norway
Prior art keywords
daily dosage
drospirenone
dosage units
ethinylestradiol
approx
Prior art date
Application number
NO20091809A
Other languages
English (en)
Inventor
Wolfgang Heil
Ralph Lipp
Renate Heithecker
Juergen Hilmann
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20091809(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/IB2000/001213 external-priority patent/WO2001015701A1/en
Publication of NO20091809L publication Critical patent/NO20091809L/no
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Priority to NO20091809A priority Critical patent/NO20091809L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives farmasøytiske materialer som omfatter som et første aktive 6?,7?,15?? 16?-dimetylen-3-okso-17?-pregn-4-en-21,17-karbolakton (drospirenon) i en mengde korresponderende til en daglig dosering, ved administrering av materialet, fra ca. 2 mg til ca. 4 mg, og som et andre aktive middel 17 ?-etinylestradiol (etinylestradiol) i en mengde korresponderende til daglig dosering av fra ca. 0,01 mg til ca. 0,05 mg, sammen med eller flere farmasøytisk akseptable bærere eller eksipienter. I en spesifikk utførelse omfatter materialet et antall separat pakkede og individuelt fjern-bare daglige doseringsenheter plassert i en pakningsenhet og tiltenkt for oral administrering på minst 21 påfølgende dager, hvorpå nevnte daglige doseringsenheter omfatter kombinasjonen av drospirenon og etinylestrediol. Materialet kan videre omfatte 7 eller mindre daglige doseringsenheter som inneholder intet aktivt middel, eller som kun inneholder etinylestradiol.
NO20091809A 1999-08-31 2009-05-07 Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel NO20091809L (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO20091809A NO20091809L (no) 1999-08-31 2009-05-07 Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
NO20020801A NO326860B1 (no) 1999-08-31 2002-02-19 Farmasoytisk sammensetning av etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
NO20091809A NO20091809L (no) 1999-08-31 2009-05-07 Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel

Publications (1)

Publication Number Publication Date
NO20091809L true NO20091809L (no) 2002-04-26

Family

ID=26153358

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20083854A NO327588B3 (no) 1999-08-31 2008-09-08 Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
NO20091809A NO20091809L (no) 1999-08-31 2009-05-07 Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
NO2010004C NO2010004I1 (no) 1999-08-31 2010-02-26 0,02 mg etinylostradiol (som betadexclathrat) og 3mg drospirenon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20083854A NO327588B3 (no) 1999-08-31 2008-09-08 Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2010004C NO2010004I1 (no) 1999-08-31 2010-02-26 0,02 mg etinylostradiol (som betadexclathrat) og 3mg drospirenon

Country Status (11)

Country Link
CN (1) CN1223350C (no)
BG (2) BG109749A (no)
CA (1) CA2382426C (no)
EE (1) EE05317B1 (no)
HR (1) HRP20020258B1 (no)
IL (2) IL197396A (no)
MX (1) MXPA02002043A (no)
NO (3) NO327588B3 (no)
RU (4) RU2269342C9 (no)
SK (1) SK287634B6 (no)
UA (1) UA81387C2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
CN111529482A (zh) * 2020-05-20 2020-08-14 祝培 十一酸睾酮缓释植入剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
KR100518102B1 (ko) * 1996-07-26 2005-10-04 와이어쓰 프로게스틴과 에스트로겐의 혼합물을 포함하는 단일상 피임약 키트

Also Published As

Publication number Publication date
HRP20020258A2 (en) 2005-02-28
RU2449796C9 (ru) 2007-10-27
EE05317B1 (et) 2010-08-16
BG65204B1 (bg) 2007-07-31
IL200482A0 (en) 2011-07-31
SK2572002A3 (en) 2002-11-06
CN1407895A (zh) 2003-04-02
UA81387C2 (en) 2008-01-10
RU2269342C2 (ru) 2006-02-10
NO20083854L (no) 2002-04-26
RU2482853C2 (ru) 2013-05-27
NO327588B1 (no) 2009-08-31
RU2396082C2 (ru) 2010-08-10
NO327588B3 (no) 2011-05-16
MXPA02002043A (es) 2003-08-20
RU2010114825A (ru) 2011-10-20
HRP20020258B1 (hr) 2007-05-31
IL197396A (en) 2010-04-29
BG109749A (bg) 2008-06-30
CA2382426C (en) 2006-02-28
RU2449796C2 (ru) 2006-02-10
NO2010004I1 (no) 2010-03-22
CN1223350C (zh) 2005-10-19
RU2269342C9 (ru) 2007-10-27
RU2005131868A (ru) 2007-04-20
SK287634B6 (sk) 2011-04-05
BG106533A (bg) 2002-10-31
CA2382426A1 (en) 2001-03-08
EE200900049A (et) 2009-10-15

Similar Documents

Publication Publication Date Title
NO20020801L (no) Farmasoytisk materiale av etinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
NO20091809L (no) Farmasoytisk materiale av entinylestradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
BG66095B1 (bg) Хидрофилен състав с контролирано освобождаване съдържащ прежелатинирано нишесте в препарат
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
AP1954A (en) Controlled release compositions comprising nimesulide.
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
HRP20090418T1 (hr) Farmaceutski pripravak koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate
CY1108265T1 (el) Στερεη διαστοματικη φαρμακευτικη μορφη για αντισυλληψη
KR970706004A (ko) 호르몬 약물 및 에스트로겐 결핍을 치유하기 위한 그의 용도(novel hormonal medicaments and use thereof for correcting oestrogen deficiencies)
KR890009407A (ko) 폐경기증세 및 골다공증의 치료를 위한 약학적 투여단위
NO20072687L (no) Farmasoytisk prevensjonspreparat
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method
CA2248841A1 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
TW200638951A (en) Solid oral pharmaceutical form for contraception
ECSP003721A (es) Una composicion farmaceutica para ser usada como anticonceptivo
EP2305267A3 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
ME01056B (me) Upotreba estradiolvalerata i dienogesta za oralno liječenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu
TH80557A (th) ผลิตภัณฑ์ทางเภสัชกรรมสำหรับการคุมกำเนิดทางช่องปาก
TH80558A (th) รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด
HRP20020666B1 (hr) Drospirenon za hormonsku nadomjesnu terapiju
UY29378A1 (es) Preparación farmaceutica para la anticoncepción oral

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application